Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 455 | 9,993 | 0 | 0 | 0 |
| Gross Profit | 455 | 9,993 | N/A | N/A | N/A |
| Operating Expenses | 104,754 | 74,528 | 82,950 | 105,618 | 94,466 |
| Operating Income | -104,299 | -64,535 | -82,950 | -105,618 | -94,466 |
| Other Income | -1,325 | -55,228 | 442 | 34 | 505 |
| Pre-tax Income | -105,624 | -119,763 | -82,508 | -105,584 | -93,961 |
| Net Income Continuous | -105,624 | -119,763 | -82,508 | -105,584 | -93,961 |
| Net Income | $-105,624 | $-119,763 | $-82,508 | $-105,584 | $-93,961 |
| EPS Basic Total Ops | -0.76 | -1.42 | -2.18 | -4.12 | -4.28 |
| EPS Basic Continuous Ops | -0.76 | -1.42 | -2.18 | -4.12 | -4.28 |
| EPS Diluted Total Ops | -0.76 | -1.42 | -2.18 | -4.12 | -4.28 |
| EPS Diluted Continuous Ops | -0.76 | -1.42 | -2.18 | -4.12 | -4.28 |
| EPS Diluted Before Non-Recurring Items | -0.73 | -1.42 | -2.06 | -4.12 | -4.28 |
| EBITDA(a) | $-103,307 | $-62,070 | $-78,918 | $-100,921 | $-91,534 |